BALPHARMA.BOBALPHARMA.BOBSE
Loading
Year-over-year revenue growth rate
3Y CAGR
+119.7%/yr
Quarterly compound
Percentile
P87
Within normal range
vs 3Y Ago
10.6x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 18.46% |
| Q3 2025 | 12.38% |
| Q2 2025 | -19.55% |
| Q1 2025 | 11.92% |
| Q4 2024 | -0.73% |
| Q3 2024 | -0.89% |
| Q2 2024 | -21.42% |
| Q1 2024 | 15.87% |
| Q4 2023 | -11.76% |
| Q3 2023 | 31.89% |
| Q2 2023 | -14.90% |
| Q1 2023 | 7.61% |
| Q4 2022 | 1.74% |
| Q3 2022 | 7.83% |
| Q2 2022 | -5.69% |
| Q1 2022 | 7.06% |
| Q4 2021 | 2.97% |
| Q3 2021 | -5.16% |
| Q2 2021 | 0.02% |
| Q1 2021 | 12.35% |
| Q4 2020 | -2.37% |
| Q3 2020 | 23.85% |
| Q2 2020 | 54.36% |
| Q1 2020 | -21.77% |
| Q4 2019 | -4.03% |
| Q3 2019 | -8.49% |
| Q2 2019 | -10.73% |
| Q1 2019 | 2.81% |
| Q4 2018 | -6.81% |
| Q3 2018 | 7.31% |
| Q2 2018 | -9.06% |
| Q1 2018 | 13.19% |
| Q4 2017 | -5.06% |
| Q3 2017 | 19.21% |
| Q2 2017 | -28.54% |
| Q1 2017 | 9.72% |
| Q4 2016 | -11.48% |
| Q3 2016 | 48.48% |
| Q2 2016 | -18.60% |
| Q1 2016 | 18.25% |